Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies

Brian Till

Optimization of adoptive immunotherapy with autologous CD20-specific T cells

Non-Hodgkin lymphoma

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Leukaemia

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Daniel McVicar

Characterization of the Expression and Ligands of KIR3DS2

Leukaemia

Pathology Hematology and hematologic malignancies

Margaret A Shipp

Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies

Hodgkin lymphoma

Pathology

Irving L. Weissman

HSC Diversity, in aging, ontogeny, and transformation

Leukaemia

Katy Rezvani

Curative Cell-based Therapies for Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Ravindra Majeti

Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML

Leukaemia

Hematology and hematologic malignancies

Wei Gu

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Non-Hodgkin lymphoma